AC
BMY icon

AlphaCore Capital’s Bristol-Myers Squibb BMY Stock Holding History

AlphaCore Capital’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.67M Sell
46,389
-261
-0.6% -$15K 0.05% 271
2026
Q1 		$2.83M Buy
46,650
+6,004
+15% +$350K 0.07% 212
2025
Q4 		$2.19M Buy
40,646
+16,199
+66% +$779K 0.05% 254
2025
Q3 		$1.1M Buy
24,447
+1,952
+9% +$91.2K 0.04% 281
2025
Q2 		$1.04M Buy
22,495
+3,459
+18% +$170K 0.04% 255
2025
Q1 		$1.16M Buy
19,036
+354
+2% +$20.6K 0.1% 156
2024
Q4 		$1.06M Sell
18,682
-575
-3% -$32.1K 0.23% 74
2024
Q3 		$996K Sell
19,257
-2,919
-13% -$137K 0.22% 75
2024
Q2 		$921K Sell
22,176
-2,036
-8% -$91.1K 0.22% 72
2024
Q1 		$1.31M Buy
24,212
+1,964
+9% +$100K 0.35% 53
2023
Q4 		$1.14M Sell
22,248
-5,257
-19% -$276K 0.17% 92
2023
Q3 		$1.6M Sell
27,505
-14,025
-34% -$859K 0.25% 68
2023
Q2 		$2.66M Buy
41,530
+27,955
+206% +$1.87M 0.43% 50
2023
Q1 		$941K Buy
13,575
+103
+0.8% +$7.26K 0.25% 56
2022
Q4 		$969K Buy
13,472
+1,446
+12% +$109K 0.38% 31
2022
Q3 		$855K Buy
12,026
+3,392
+39% +$246K 0.39% 27
2022
Q2 		$665K Buy
8,634
+3,124
+57% +$238K 0.31% 35
2022
Q1 		$402K Buy
+5,510
New +$370K 0.16% 50
2020
Q2 		– Sell
-888
Closed -$49K – 99
2020
Q1 		$49K Buy
+888
New +$54.3K 0.04% 105

Other funds holding BMY

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

AlphaCore Capital's BMY Position: Q2 2026 in Review

AlphaCore Capital reduced its Bristol-Myers Squibb (BMY) stake by 0.56% in Q2 2026, selling an estimated $15K and leaving 46,389 shares worth $2.67M. The position accounts for 0.05% of the portfolio, ranked #271.

AlphaCore Capital first reported a position in BMY in Q1 2020 and has held it in 19 quarters since. The position peaked at $2.83M in Q1 2026. 2,523 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • AlphaCore Capital held 46,389 shares of Bristol-Myers Squibb worth $2.67M as of Q2 2026.
  • AlphaCore Capital sold 261 Bristol-Myers Squibb shares in Q2 2026, an estimated $15K.
  • Bristol-Myers Squibb made up 0.05% of AlphaCore Capital's portfolio in Q2 2026, its #271 holding.
  • AlphaCore Capital first reported a position in Bristol-Myers Squibb in Q1 2020 and has held it in 19 quarters since.
  • AlphaCore Capital's Bristol-Myers Squibb position peaked at $2.83M in Q1 2026.
  • 2,523 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on AlphaCore Capital's 13F filing for Q2 2026, filed 6 Aug 2026.